Tormentic acid has been researched along with 11-keto-boswellic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubry, EM; Brandstötter, S; Gumy, C; Kratschmar, DV; Odermatt, A; Pfisterer, PH; Rollinger, JM; Schuster, D; Stuppner, H; Wolber, G | 1 |
| Gou, W; Guo, J; Hou, W; Li, Y; Liu, Q; Ning, H; Shang, H; Sun, X; Wei, H | 1 |
1 review(s) available for Tormentic acid and 11-keto-boswellic acid
| Article | Year |
|---|---|
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Cysteine Endopeptidases; Drug Resistance, Neoplasm; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Structure-Activity Relationship; Triterpenes | 2022 |
1 other study(ies) available for Tormentic acid and 11-keto-boswellic acid
| Article | Year |
|---|---|
11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Biological Assay; Cell Line; Database Management Systems; Drug Evaluation, Preclinical; Enzyme Inhibitors; Eriobotrya; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2010 |